Income Statement Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris Other stock markets 14:14:25 14/05/2026 BST			5-day change	1st Jan Change
73.24 ^EUR	+0.72%		-0.65%	-11.44%

05-08	A lot of noise, little impact?
05-08	Berenberg Calls for More Acquisitions from Sanofi; Estimates Updated	MT

578aec8.JrNpF5X-2Yx6PG7P9y5GpwX1RQlAJSGhwcyz2TtjeMU.E-shYtLIrbU9WSSDkR5z7XOsKyQEXBTNqIXbqGoqS49u2jpQ3b_g_BxENw

Published financial data: SANOFI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	37.76B	43B	43.07B	41.08B	43.63B
Other Revenues, Total	1.41B	2.39B	2.96B	3.2B	3.09B
Total Revenues	39.18B	45.39B	46.03B	44.29B	46.72B
Cost of Goods Sold, Total	12.25B	13.69B	14.22B	13.2B	12.92B
Gross Profit	26.92B	31.7B	31.82B	31.09B	33.79B
Selling General & Admin Expenses, Total	9.6B	10.54B	10.76B	9.25B	9.62B
R&D Expenses	5.69B	6.71B	6.73B	7.39B	7.84B
Amortization of Goodwill and Intangible Assets - (IS)	1.58B	1.83B	2.17B	1.75B	1.78B
Other Operating Expenses	1.48B	1.59B	2.95B	3.83B	4.91B
Other Operating Expenses, Total	18.35B	20.66B	22.62B	22.22B	24.14B
Operating Income	8.58B	11.04B	9.2B	8.87B	9.65B
Interest Expense, Total	-362M	-394M	-527M	-641M	-531M
Interest And Investment Income	3M	173M	546M	413M	320M
Net Interest Expenses	-359M	-221M	19M	-228M	-211M
Income (Loss) On Equity Invest.	39M	68M	-115M	60M	-155M
Currency Exchange Gains (Loss)	2M	-4M	-2M	6M	2M
Other Non Operating Income (Expenses)	70M	37M	-665M	-268M	122M
EBT, Excl. Unusual Items	8.33B	10.92B	8.44B	8.44B	9.41B
Restructuring Charges	-820M	-1.34B	-1.49B	-1.4B	-1.14B
Merger & Related Restructuring Charges	-17M	-3M	-20M	-10M	-126M
Gain (Loss) On Sale Of Investments	3M	1M	-1M	-	-9M
Gain (Loss) On Sale Of Assets	418M	655M	688M	539M	485M
Asset Writedown	-192M	228M	-896M	-248M	-2.24B
Legal Settlements	-	-	-	-470M	-255M
Other Unusual Items	115M	27M	318M	-96M	-104M
EBT, Incl. Unusual Items	7.84B	10.49B	7.04B	6.76B	6.02B
Income Tax Expense	1.56B	2.01B	1.6B	1.2B	1.04B
Earnings From Continuing Operations	6.28B	8.48B	5.44B	5.55B	4.98B
Earnings Of Discontinued Operations	-	-	-	64M	2.87B
Net Income to Company	6.28B	8.48B	5.44B	5.62B	7.85B
Minority Interest	-56M	-113M	-36M	-58M	-38M
Net Income - (IS)	6.22B	8.37B	5.4B	5.56B	7.81B
Net Income to Common Incl Extra Items	6.22B	8.37B	5.4B	5.56B	7.81B
Net Income to Common Excl. Extra Items	6.22B	8.37B	5.4B	5.5B	4.94B
Per Share Items
Net EPS - Basic	4.97	6.69	4.31	4.44	6.4
Basic EPS - Continuing Operations	4.97	6.69	4.31	4.39	4.05
Basic Weighted Average Shares Outstanding	1.25B	1.25B	1.25B	1.25B	1.22B
Net EPS - Diluted	4.95	6.66	4.3	4.44	6.37
Diluted EPS - Continuing Operations	4.95	6.66	4.3	4.39	4.03
Diluted Weighted Average Shares Outstanding	1.26B	1.26B	1.26B	1.26B	1.23B
Normalized Basic EPS	4.11	5.36	4.19	4.17	4.79
Normalized Diluted EPS	4.09	5.34	4.17	4.15	4.77
Dividend Per Share	3.33	3.56	3.76	3.92	4.12
Payout Ratio	64.41	49.79	82.48	84.6	61.08
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	11.26B	14.06B	12.52B	11.66B	12.64B
EBITA	10.2B	12.91B	11.43B	10.96B	11.46B
EBIT	8.58B	11.04B	9.2B	8.87B	9.65B
EBITDAR	11.29B	14.09B	12.54B	11.68B	-
Effective Tax Rate - (Ratio)	19.88	19.12	22.76	17.82	17.33
Total Current Taxes	1.91B	2.77B	2.56B	2.15B	3.44B
Total Deferred Taxes	-350M	-768M	-958M	-948M	-2.39B
Normalized Net Income	5.15B	6.71B	5.24B	5.22B	5.84B
Interest Capitalized	14M	17M	26M	51M	48M
Interest on Long-Term Debt	49M	57M	65M	93M	93M
Non-Cash Pension Expense	49M	-25M	50M	-38M	7M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	5.69B	6.71B	6.73B	7.39B	7.84B
Net Rental Expense, Total	25M	26M	19M	16M	-
Imputed Operating Lease Interest Expense	3.26M	3.92M	4.24M	4.88M	-
Imputed Operating Lease Depreciation	21.74M	22.08M	14.76M	11.12M	-
Stock-Based Comp., Other (Total)	244M	245M	283M	278M	313M
Total Stock-Based Compensation	244M	245M	283M	278M	313M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	10.1B	12.74B	8.71B	7.44B	7.66B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	11M	-	-	115M	17M
Total Cash And Short Term Investments	10.11B	12.74B	8.71B	7.56B	7.67B
Accounts Receivable, Total	7.57B	8.42B	8.43B	7.68B	8.41B
Other Receivables	2.22B	2.32B	2.61B	2.95B	2.64B
Total Receivables	9.79B	10.75B	11.04B	10.63B	11.05B
Inventory	8.72B	8.96B	9.67B	9.43B	10.21B
Prepaid Expenses	615M	714M	768M	895M	918M
Other Current Assets, Total	1.43B	955M	486M	14.08B	1.1B
Total Current Assets	30.65B	34.11B	30.67B	42.59B	30.95B
Gross Property Plant And Equipment	27.56B	26.8B	27.44B	26.67B	25.98B
Accumulated Depreciation	-15.58B	-15.11B	-15.63B	-15.07B	-14.46B
Net Property Plant And Equipment	11.98B	11.68B	11.81B	11.6B	11.51B
Long-term Investments	2.42B	2.76B	2.67B	3.26B	6.85B
Goodwill	48.06B	49.89B	49.4B	43.38B	41.3B
Other Intangibles, Total	13.68B	15.41B	18.28B	14.26B	17.53B
Loans Receivable Long-Term	485M	452M	591M	502M	393M
Deferred Tax Assets Long-Term	4.6B	5.38B	6.43B	7.97B	8.61B
Deferred Charges Long-Term	7.73B	6.23B	6.04B	8.37B	8.73B
Other Long-Term Assets, Total	642M	797M	573M	868M	928M
Total Assets	120B	127B	126B	133B	127B
Liabilities
Accounts Payable, Total	6.18B	6.81B	7.33B	7.55B	7.36B
Accrued Expenses, Total	2.55B	2.58B	2.5B	2.37B	2.32B
Short-term Borrowings	189M	164M	203M	200M	240M
Current Portion of Long-Term Debt	3B	4.01B	1.84B	4.02B	4.1B
Current Portion of Leases	269M	277M	275M	261M	272M
Current Income Taxes Payable	309M	574M	597M	697M	751M
Unearned Revenue Current, Total	319M	264M	-	-	-
Other Current Liabilities	8.48B	9.29B	11.46B	14.07B	13.3B
Total Current Liabilities	21.3B	23.97B	24.21B	29.16B	28.34B
Long-Term Debt	17.12B	14.86B	14.35B	11.79B	14.25B
Long-Term Leases	1.84B	1.9B	1.76B	1.64B	1.47B
Pension & Other Post Retirement Benefits	2.95B	2.04B	2.21B	1.99B	1.44B
Deferred Tax Liability Non Current	1.62B	1.84B	1.86B	2.17B	1.67B
Other Non Current Liabilities	6.39B	6.96B	7.73B	8.18B	7.93B
Total Liabilities	51.21B	51.57B	52.11B	54.94B	55.1B
Common Stock, Total	2.53B	2.52B	2.53B	2.53B	2.44B
Additional Paid In Capital	532M	125M	313M	-	1M
Treasury Stock	-939M	-706M	-1.18B	-840M	-1.07B
Comprehensive Income and Other	66.56B	72.84B	72.38B	75.82B	70.01B
Total Common Equity	68.68B	74.78B	74.04B	77.51B	71.38B
Minority Interest	350M	368M	313M	350M	334M
Total Equity	69.03B	75.15B	74.35B	77.86B	71.71B
Total Liabilities And Equity	120B	127B	126B	133B	127B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.25B	1.25B	1.25B	1.25B	1.21B
ECS Total Common Shares Outstanding	1.25B	1.25B	1.25B	1.25B	1.21B
Book Value / Share	54.83	59.7	59.17	61.83	59.1
Tangible Book Value	6.95B	9.48B	6.36B	19.86B	12.55B
Tangible Book Value Per Share	5.55	7.57	5.08	15.84	10.39
Total Debt	22.42B	21.21B	18.42B	17.91B	20.33B
Net Debt	12.31B	8.48B	9.71B	10.36B	12.66B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.52B	1.75B	1.94B	1.83B	1.24B
Debt Equivalent Oper. Leases	200M	208M	152M	128M	-
Minority Interest, Total (Incl. Fin. Div)	350M	368M	313M	350M	334M
Equity Method Investments, Total	250M	677M	424M	316M	3.26B
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	1.34B	1.61B	1.68B	1.59B	1.62B
Inventories - Work In Process, Total	5.58B	5.66B	5.87B	5.78B	6.46B
Inventories - Finished Goods, Total	2.7B	2.75B	3.04B	2.9B	3.02B
Land - (BS)	240M	237M	228M	201M	149M
Buildings, Total	7.17B	7.33B	7.68B	7.44B	7.06B
Machinery, Total	14.3B	13.36B	13.41B	12.84B	12.68B
Full Time Employees	95.44K	91.57K	86.09K	82.88K	74.85K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	137M	113M	95M	100M	100M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.22B	8.37B	5.4B	5.56B	7.81B
Depreciation & Amortization - CF	1.38B	1.49B	1.38B	1.02B	1.44B
Amortization of Goodwill and Intangible Assets - (CF)	1.62B	1.87B	2.22B	2.09B	1.81B
Depreciation & Amortization, Total	3B	3.36B	3.61B	3.11B	3.26B
Amortization of Deferred Charges, Total - (CF)	119M	97M	120M	106M	112M
Minority Interest in Earnings - (CF)	56M	113M	36M	58M	38M
(Gain) Loss From Sale Of Asset	-357M	-573M	-226M	-298M	-79M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	231M	-42M	1.06B	369M	2.31B
(Income) Loss On Equity Investments - (CF)	-15M	-48M	295M	82M	290M
Stock-Based Compensation (CF)	244M	245M	283M	278M	313M
Net Cash From Discontinued Operations	-	-	-	474M	189M
Other Operating Activities, Total	-389M	-295M	-1.09B	-44M	-5.29B
Change In Accounts Receivable	185M	-777M	-397M	-28M	-1.2B
Change In Inventories	-357M	-927M	-840M	-477M	-39M
Change In Accounts Payable	451M	452M	402M	789M	398M
Change in Other Net Operating Assets	1.13B	545M	1.6B	-899M	2.64B
Cash from Operations	10.52B	10.53B	10.26B	9.08B	10.75B
Capital Expenditure	-1.48B	-1.61B	-1.72B	-1.73B	-1.76B
Sale of Property, Plant, and Equipment	718M	1.49B	1.02B	1.46B	847M
Cash Acquisitions	-5.59B	-992M	-3.87B	-1.9B	-9.39B
Sale (Purchase) of Intangible assets	-564M	-595M	-1.3B	-1.46B	-1.78B
Investment in Marketable and Equity Securities, Total	-311M	-354M	-92M	-623M	-684M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-68M	-16M	-229M	-149M	10.32B
Cash from Investing	-7.3B	-2.08B	-6.2B	-4.41B	-2.45B
Short Term Debt Issued, Total	-	215M	765M	59M	-
Long-Term Debt Issued, Total	-	1.55B	48M	-	5.56B
Total Debt Issued	-	1.76B	813M	59M	5.56B
Short Term Debt Repaid, Total	-414M	-	-	-	-1.1B
Long-Term Debt Repaid, Total	-2.39B	-3.01B	-3.95B	-953M	-2.96B
Total Debt Repaid	-2.8B	-3.01B	-3.95B	-953M	-4.06B
Issuance of Common Stock	186M	188M	195M	187M	177M
Repurchase of Common Stock	-382M	-497M	-593M	-302M	-5.03B
Common Dividends Paid	-4.01B	-4.17B	-4.45B	-4.7B	-4.77B
Common & Preferred Stock Dividends Paid	-4.01B	-4.17B	-4.45B	-4.7B	-4.77B
Other Financing Activities, Total	-48M	-99M	-64M	-50M	-86M
Cash from Financing	-7.06B	-5.82B	-8.05B	-5.76B	-8.21B
Foreign Exchange Rate Adjustments	15M	8M	-32M	-13M	-47M
Miscellaneous Cash Flow Adjustments	-	-	-	-167M	167M
Net Change in Cash	-3.82B	2.64B	-4.03B	-1.27B	216M
Supplemental Items
Cash Interest Paid	334M	380M	559M	587M	485M
Cash Income Tax Paid (Refund)	1.28B	2.45B	2.62B	3.29B	2.88B
Levered Free Cash Flow	7.34B	9.01B	8.19B	-4.94B	16.64B
Unlevered Free Cash Flow	7.57B	9.25B	8.52B	-4.54B	16.98B
Change In Net Working Capital	-888M	-850M	-1.78B	10.38B	-10.8B
Net Debt Issued / Repaid	-2.8B	-1.24B	-3.14B	-894M	1.5B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.57	5.59	4.54	4.28	4.65
Return on Total Capital	6.01	7.35	6.08	5.88	6.42
Return On Equity %	9.49	11.77	7.27	7.3	6.66
Return on Common Equity	9.44	11.67	7.26	7.25	6.63
Margin Analysis
Gross Profit Margin %	68.73	69.83	69.12	70.2	72.34
SG&A Margin	24.5	23.22	23.39	20.88	20.58
EBITDA Margin %	28.75	30.98	27.2	26.34	27.05
EBITA Margin %	26.03	28.45	24.82	24.76	24.54
EBIT Margin %	21.9	24.32	19.99	20.03	20.66
Income From Continuing Operations Margin %	16.03	18.69	11.81	12.54	10.65
Net Income Margin %	15.89	18.44	11.73	12.55	16.72
Net Avail. For Common Margin %	15.89	18.44	11.73	12.41	10.57
Normalized Net Income Margin	13.15	14.78	11.38	11.78	12.51
Levered Free Cash Flow Margin	18.75	19.85	17.79	-11.16	35.63
Unlevered Free Cash Flow Margin	19.32	20.39	18.5	-10.26	36.34
Asset Turnover
Asset Turnover	0.33	0.37	0.36	0.34	0.36
Fixed Assets Turnover	3.48	3.84	3.92	3.78	4.04
Receivables Turnover (Average Receivables)	5.02	5.38	5.11	5.1	5.42
Inventory Turnover (Average Inventory)	1.44	1.55	1.53	1.38	1.32
Short Term Liquidity
Current Ratio	1.44	1.42	1.27	1.46	1.09
Quick Ratio	0.93	0.98	0.82	0.62	0.66
Operating Cash Flow to Current Liabilities	0.49	0.44	0.42	0.31	0.38
Days Sales Outstanding (Average Receivables)	72.78	67.88	71.43	71.76	67.3
Days Outstanding Inventory (Average Inventory)	254.24	235.59	239.11	264.85	277.43
Average Days Payable Outstanding	166.02	170.14	172.95	210.1	198.56
Cash Conversion Cycle (Average Days)	161	133.33	137.59	126.52	146.17
Long Term Solvency
Total Debt/Equity	32.47	28.23	24.78	23.01	28.35
Total Debt / Total Capital	24.51	22.01	19.86	18.7	22.09
LT Debt/Equity	27.47	22.3	21.66	17.26	21.91
Long-Term Debt / Total Capital	20.74	17.39	17.36	14.03	17.07
Total Liabilities / Total Assets	42.59	40.7	41.21	41.37	43.45
EBIT / Interest Expense	23.7	28.02	17.46	13.84	18.17
EBITDA / Interest Expense	31.99	36.56	24.31	18.69	24.31
(EBITDA - Capex) / Interest Expense	27.9	32.48	21.05	15.99	20.99
Total Debt / EBITDA	1.94	1.47	1.44	1.5	1.58
Net Debt / EBITDA	1.06	0.59	0.76	0.86	0.98
Total Debt / (EBITDA - Capex)	2.22	1.66	1.66	1.75	1.82
Net Debt / (EBITDA - Capex)	1.22	0.66	0.88	1.01	1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.83	15.86	1.42	7.73	5.49
Gross Profit, 1 Yr. Growth %	6.57	17.73	0.38	9.13	8.69
EBITDA, 1 Yr. Growth %	7.55	24.98	-10.97	5.32	8.34
EBITA, 1 Yr. Growth %	9.75	26.75	-11.49	5.96	4.55
EBIT, 1 Yr. Growth %	13.08	28.87	-16.63	9.21	8.81
Earnings From Cont. Operations, 1 Yr. Growth %	-49.08	35.12	-35.93	8.94	-10.39
Net Income, 1 Yr. Growth %	-49.38	34.52	-35.49	2.96	40.52
Normalized Net Income, 1 Yr. Growth %	8.38	30.51	-21.94	14.5	11.99
Diluted EPS Before Extra, 1 Yr. Growth %	-49.28	34.55	-35.44	8.55	-8.2
Accounts Receivable, 1 Yr. Growth %	1.03	11.31	0.11	-8.96	9.55
Inventory, 1 Yr. Growth %	4.35	2.81	7.88	-2.43	8.3
Net Property, Plant and Equip., 1 Yr. Growth %	13.38	-2.44	1.11	-1.8	-0.78
Total Assets, 1 Yr. Growth %	5.09	5.39	-0.2	5.01	-4.51
Tangible Book Value, 1 Yr. Growth %	7.01	36.41	-32.95	212.56	-36.84
Common Equity, 1 Yr. Growth %	8.83	8.89	-0.99	4.68	-7.91
Cash From Operations, 1 Yr. Growth %	41.84	0.04	-2.55	-11.47	18.38
Capital Expenditures, 1 Yr. Growth %	17.94	8.59	7.04	7.04	1.67
Levered Free Cash Flow, 1 Yr. Growth %	16.79	22.8	-9.1	-168.91	-436.67
Unlevered Free Cash Flow, 1 Yr. Growth %	15.13	22.38	-7.96	-160.23	-473.67
Dividend Per Share, 1 Yr. Growth %	4.06	6.91	5.62	4.26	5.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.03	10.21	8.4	4.82	6.6
Gross Profit, 2 Yr. CAGR %	2.44	12.01	8.71	4.57	8.91
EBITDA, 2 Yr. CAGR %	5.54	15.91	5.49	-5.61	6.82
EBITA, 2 Yr. CAGR %	6.64	17.91	5.92	-5.41	5.26
EBIT, 2 Yr. CAGR %	12.3	20.68	3.65	-7.57	9.01
Earnings From Cont. Operations, 2 Yr. CAGR %	47.5	-17.05	-6.95	-17.11	-1.19
Net Income, 2 Yr. CAGR %	50.32	-17.48	-6.85	-18.5	20.29
Normalized Net Income, 2 Yr. CAGR %	10.15	18.89	0.93	-8.98	13.24
Diluted EPS Before Extra, 2 Yr. CAGR %	47.67	-17.39	-6.8	-16.85	-0.17
Accounts Receivable, 2 Yr. CAGR %	-2.35	6.04	5.56	-4.54	-0.14
Inventory, 2 Yr. CAGR %	4.41	3.58	5.31	2.59	2.8
Net Property, Plant and Equip., 2 Yr. CAGR %	4.26	5.17	-0.68	-0.36	-1.29
Total Assets, 2 Yr. CAGR %	3.32	5.24	2.55	2.37	0.13
Tangible Book Value, 2 Yr. CAGR %	338.1	20.82	-4.36	44.77	40.51
Common Equity, 2 Yr. CAGR %	7.84	8.86	3.83	1.8	-1.82
Cash From Operations, 2 Yr. CAGR %	16.78	19.12	-1.26	-7.12	2.37
Capital Expenditures, 2 Yr. CAGR %	5.73	13.17	7.85	6.46	4.32
Levered Free Cash Flow, 2 Yr. CAGR %	19.88	19.73	5.65	-23.81	52.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	17.85	18.68	6.13	-28.02	50.05
Dividend Per Share, 2 Yr. CAGR %	2.82	5.48	6.26	4.93	4.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.17	6.45	7.2	4.17	5.04
Gross Profit, 3 Yr. CAGR %	3.4	7.3	7.99	4.91	5.92
EBITDA, 3 Yr. CAGR %	6.36	11.61	6.16	1.21	-1.17
EBITA, 3 Yr. CAGR %	7.49	12.91	7.16	2.48	-2.2
EBIT, 3 Yr. CAGR %	12.5	17.51	6.68	1.17	-2.4
Earnings From Cont. Operations, 3 Yr. CAGR %	12.39	43.25	-23.89	-4.01	-14.93
Net Income, 3 Yr. CAGR %	13.06	44.86	-23.98	-3.69	-2.27
Normalized Net Income, 3 Yr. CAGR %	10.56	16.5	3.33	0.48	-2.47
Diluted EPS Before Extra, 3 Yr. CAGR %	12.9	43.16	-23.91	-3.92	-14.06
Accounts Receivable, 3 Yr. CAGR %	1.39	2	4.03	0.48	-0.06
Inventory, 3 Yr. CAGR %	5.24	3.88	4.99	2.67	4.46
Net Property, Plant and Equip., 3 Yr. CAGR %	7.46	1.98	3.8	-1.05	-0.5
Total Assets, 3 Yr. CAGR %	2.58	4.01	3.39	3.37	0.02
Tangible Book Value, 3 Yr. CAGR %	40.52	196.94	-0.71	41.93	9.8
Common Equity, 3 Yr. CAGR %	5.27	8.19	5.47	4.11	-1.54
Cash From Operations, 3 Yr. CAGR %	23.79	10.91	11.41	-4.79	0.7
Capital Expenditures, 3 Yr. CAGR %	1.49	6.67	11.09	5.45	4.84
Levered Free Cash Flow, 3 Yr. CAGR %	20.79	20.8	9.23	-12.33	25.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.27	19.3	9.04	-15.63	24.65
Dividend Per Share, 3 Yr. CAGR %	2.75	4.16	5.52	5.59	4.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.46	4.62	5.23	3.31	4.57
Gross Profit, 5 Yr. CAGR %	2.33	5.05	5.49	3.92	5.99
EBITDA, 5 Yr. CAGR %	1.69	6.47	5.98	2.9	3.84
EBITA, 5 Yr. CAGR %	2.02	7.11	6.83	4.1	4.3
EBIT, 5 Yr. CAGR %	2.67	8.7	8.84	5.45	4.95
Earnings From Cont. Operations, 5 Yr. CAGR %	6.96	16.85	4.21	13.99	-16.59
Net Income, 5 Yr. CAGR %	5.73	-0.11	4.63	15.09	-8.67
Normalized Net Income, 5 Yr. CAGR %	3.09	8.98	6.57	4.21	4.24
Diluted EPS Before Extra, 5 Yr. CAGR %	7.87	17.45	4.56	14.1	-16.21
Accounts Receivable, 5 Yr. CAGR %	0.69	3.14	3.04	-0.66	2.34
Inventory, 5 Yr. CAGR %	4.79	5.62	5.27	3.36	4.11
Net Property, Plant and Equip., 5 Yr. CAGR %	3.63	4.05	4.13	1.04	1.73
Total Assets, 5 Yr. CAGR %	2.81	4.89	2.57	3.35	2.08
Tangible Book Value, 5 Yr. CAGR %	-2.15	8.86	20.47	122.78	14.08
Common Equity, 5 Yr. CAGR %	3.6	5.19	4.69	5.59	2.49
Cash From Operations, 5 Yr. CAGR %	6.07	7.36	13.08	3.31	7.7
Capital Expenditures, 5 Yr. CAGR %	3.94	2.96	3.97	5.55	7.04
Levered Free Cash Flow, 5 Yr. CAGR %	5.03	-3.62	14.46	-0.67	21.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.86	-3.48	13.81	-3.58	20.9
Dividend Per Share, 5 Yr. CAGR %	2.38	3.28	4.14	4.47	5.18